{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:11:59Z","timestamp":1779275519634,"version":"3.51.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Portal vein thrombosis (PVT) is a severe complication of liver cirrhosis, yet reliable early warning methods are lacking. As PVT is strongly associated with portal hypertension, liver stiffness measurement (LSM) serves as a noninvasive marker for assessing portal hypertension. Hence, the association between LSM and PVT requires further exploration. A total of 202 cirrhotic patients were enrolled and divided into PVT (n\u2005=\u200529) and non-PVT (n\u2005=\u2005173) groups. Baseline data, laboratory indices, and LSM were compared between the groups. Risk factors were analyzed using logistic regression, and the diagnostic value of LSM was evaluated using receiver operating characteristic (ROC) curves. The PVT group showed significantly higher levels of total bilirubin (TB), prothrombin time (PT), Child-Turcotte-Pugh (CTP) score, and LSM (26.2 kPa vs 13.8 kPa,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). and lower albumin (ALB) and platelet count (PLT), Multivariate analysis identified LSM (OR\u2005=\u20051.045,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.018) and CTP grade (OR\u2005=\u20055.132,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.007) as independent risk factors. The area under the ROC curve (AUC) for LSM in predicting PVT was 0.768 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), with an optimal cutoff of 22.6 kPa (sensitivity, 65.5%; specificity, 79.2%). LSM demonstrated higher diagnostic efficacy in patients with CTP scores\u2005\u2265\u20056 (AUC\u2005=\u20050.762,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) compared to those with CTP scores\u2005&lt;\u20056 (AUC\u2005=\u20050.426,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.61). Elevated LSM and CTP scores are independently associated with PVT. LSM exhibits greater diagnostic efficacy in patients with CTP scores\u2005\u2265\u20056. The combination of LSM and CTP score can serve as a critical indicator for early warning of PVT in patients with cirrhosis, prompting further diagnostic evaluation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045520","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:02:39Z","timestamp":1763571759000},"page":"e45520","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between liver stiffness measurement and portal vein thrombosis among patients with cirrhosis: A cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiaohang","family":"Shan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Liver Diseases The Second Hospital of Nanjing, Teaching Hospital of Southeast University, Nanjing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Liver Diseases The Second Hospital of Nanjing, Teaching Hospital of Southeast University, Nanjing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Liver Diseases The Second Hospital of Nanjing, Teaching Hospital of Southeast University, Nanjing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Liver Diseases The Second Hospital of Nanjing, Teaching Hospital of Southeast University, Nanjing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-0038","authenticated-orcid":false,"given":"Yongfeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Liver Diseases The Second Hospital of Nanjing, Teaching Hospital of Southeast University, Nanjing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3748\/wjg.v25.i31.4437","article-title":"Portal vein thrombosis in cirrhosis: why a well-known complication is still matter of debate.","volume":"25","author":"Faccia","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/jcm11030800","article-title":"The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into virchow\u2019s triad.","volume":"11","author":"Anton","year":"2022","journal-title":"J Clin Med"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"209","DOI":"10.14740\/jocmr4718","article-title":"Risk factors, clinical presentation, diagnosis, and treatment outcomes of portal vein thrombosis: a five-year hospital-based study from Qatar.","volume":"14","author":"Khan","year":"2022","journal-title":"J Clin Med Res"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1665-2681(19)30797-5","article-title":"Portal vein thrombosis: what is new?","volume":"14","author":"Manzano-Robleda","year":"2015","journal-title":"Ann Hepatol"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.3390\/jcm11216435","article-title":"Portal vein thrombosis in the setting of cirrhosis: a comprehensive review.","volume":"11","author":"Odriozola","year":"2022","journal-title":"J Clin Med"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1007\/s00268-011-1198-0","article-title":"Management of acute non\u2010cirrhotic and non\u2010malignant portal vein thrombosis: a systematic review.","volume":"35","author":"Hall","year":"2011","journal-title":"World J Surg"},{"key":"R7-20260520","first-page":"1","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy.","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case\u2010control study.","volume":"38","author":"Stine","year":"2017","journal-title":"Liver Int"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease.","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2014.12.007","article-title":"Real-time shear-wave elastography: APPLICABILITY, reliability and accuracy for clinically significant portal hypertension.","volume":"62","author":"Procopet","year":"2015","journal-title":"J Hepatol"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension.","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.3748\/wjg.v26.i45.7088","article-title":"Chinese guidelines on the management of liver cirrhosis (abbreviated version).","volume":"26","author":"Xu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/liv.15435","article-title":"Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis.","volume":"43","author":"Zanetto","year":"2022","journal-title":"Liver Int"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease.","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/ajcn\/nqac059","article-title":"Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population.","volume":"115","author":"Ciardullo","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13098-023-01016-x","article-title":"Association between antidepressant use and liver fibrosis in patients with type 2 diabetes: a population based study.","volume":"15","author":"Shi","year":"2023","journal-title":"Diabetol Metabol Syndrome"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient.","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep"},{"key":"R20-20260520","first-page":"252","article-title":"Progress in predictive factors of portal vein thrombosis [Chinese].","volume":"45","author":"Sun","year":"2024","journal-title":"J Shandong First Med Univ (Shandong Acad Med Sci)"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","article-title":"Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.","volume":"17","author":"Mangia","year":"2005","journal-title":"Eu J Gastroenterol Hepatol"},{"key":"R22-20260520","first-page":"739","article-title":"Platelet activation is upregulated in cirrhotic patients with portal vein thrombosis.","volume":"124","author":"Zhao","year":"2023","journal-title":"Thromb Haemost"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.gastro.2024.05.017","article-title":"Portal vein thrombosis in the setting of cirrhosis: evaluation and management strategies.","volume":"167","author":"Hilscher","year":"2024","journal-title":"Gastroenterology"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MCG.0000000000000834","article-title":"Portal vein thrombosis in cirrhosis.","volume":"51","author":"Loudin","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrgastro.2013.258","article-title":"Imaging in clinical decision-making for portal vein thrombosis.","volume":"11","author":"Berzigotti","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7861\/clinmedicine.17-3-212","article-title":"Portal vein thrombosis \u2013 a primer for the general physician.","volume":"17","author":"Harris","year":"2017","journal-title":"Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:03:52Z","timestamp":1779275032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":25,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045520","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}